reported elevated whole blood GSSG levels in clinically stable medicated schizophrenia patients [18, 31], while Raffa et al
What troubles me at the beginning of a medical career in a city with one of the largest concentrations of Medi-Cal patients in California is that the decision to deny GLP-1 medication coverage will result in a higher number of uncontrolled diabetes cases and a rise in cardiovascular events
A blue/blue-green tint after mixing is normal for copper peptides
The lack of evidence-based diagnostic guidelines, a paucity of correlative diagnostic parameters, inconsistent symptomatology, limited physician knowledge, and lack of coordinated physician networks collectively present challenges for both patients and providers
Insurance changes, supply shortages, side effect management, and cost considerations drive many to make this transition